In LCH and other neoplasms harboring the BRAF-V600E mutation, ERK activation occurs independently of RAS or dimerization, promoting increased cellular survival, proliferation, and differentiation [13]. The gene discussed is BRAF; the disease is Langerhans cell histiocytosis.